Robert Forgey
Directeur Général chez Iaso Therapeutics, Inc.
Profil
Robert Forgey is the founder of Sierra Oncology, Inc. which was founded in 2004.
He was the Chief Operating Officer & Director in 2013.
Currently, he is the President & Chief Executive Officer at Iaso Therapeutics, Inc. since 2020.
He has worked as a Manager at Pfizer Inc., Principal at G.D.
Searle & Co., Inc., and Principal at Oncology, Inc. He completed his undergraduate degree from the University of Washington in 2001 and his undergraduate and graduate degrees from the University of North Dakota.
Postes actifs de Robert Forgey
| Sociétés | Poste | Début |
|---|---|---|
Iaso Therapeutics, Inc.
 Iaso Therapeutics, Inc. BiotechnologyHealth Technology Iaso Therapeutics, Inc. is a start-up company spun out from Michigan State University. The company is based in East Lansing, MI. Iaso Therapeutics is dedicated to developing next-generation vaccines to enhance human health and treat diseases. The company was founded in 2018 by Dr. Huang, a MSU Foundation Professor jointly appointed in the Department of Chemistry and the Department of Biomedical Engineering. Robert Forgey has been the CEO of the company since 2020. | Directeur Général | 01/10/2020 |
Anciens postes connus de Robert Forgey
| Sociétés | Poste | Fin |
|---|---|---|
Oncology, Inc.
 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Dentsu Group, Inc., Oncology, Inc. provides oncology treatment information. The company is based in Cherry Hill, NJ. Oncology was acquired by Aegis Group Plc on January 07, 2008. | Corporate Officer/Principal | - |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
| SIERRA ONCOLOGY, INC. | Fondateur | - |
Formation de Robert Forgey
| University of Washington | Undergraduate Degree |
| University of North Dakota | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
Oncology, Inc.
Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Dentsu Group, Inc., Oncology, Inc. provides oncology treatment information. The company is based in Cherry Hill, NJ. Oncology was acquired by Aegis Group Plc on January 07, 2008. | Commercial Services |
Iaso Therapeutics, Inc.
Iaso Therapeutics, Inc. BiotechnologyHealth Technology Iaso Therapeutics, Inc. is a start-up company spun out from Michigan State University. The company is based in East Lansing, MI. Iaso Therapeutics is dedicated to developing next-generation vaccines to enhance human health and treat diseases. The company was founded in 2018 by Dr. Huang, a MSU Foundation Professor jointly appointed in the Department of Chemistry and the Department of Biomedical Engineering. Robert Forgey has been the CEO of the company since 2020. | Health Technology |